A New Era for Vaccine Innovation
Updated April 8, 2025 — This article has been revised to include LunaVax’s new initiatives in microneedle patches and biometric technologies for vaccine delivery.
At LunaVax, our mission is to transform vaccine accessibility and manufacturing across Africa. We’re reducing reliance on imports and expanding local production through bold partnerships and breakthrough tech.
With new strategic partnerships, innovative vaccine technologies, and groundbreaking delivery solutions, we are taking bold steps toward reshaping global immunization efforts.
Here’s what we’re building—and how you can be a part of it.
Strengthening Africa’s Vaccine Manufacturing Capabilities
Laying the groundwork for local vaccine hubs—designed to reduce import reliance and strengthen Africa’s health resilience.
One of the biggest barriers to vaccine accessibility is the heavy reliance on imports, leading to supply chain delays, high costs, and limited access in remote and underserved areas.
LunaVax is tackling this challenge by spearheading the development of local vaccine production hubs that will:
- Improve vaccine availability where they are needed most.
- Enhance affordability by reducing import dependency.
- Empower regional public health infrastructure for long-term sustainability.
These hubs are also designed with future readiness in mind, with plans to locally manufacture next-generation innovations such as microneedle patches (MAPs).
As we lay the groundwork, our vision is to build a scalable, self-sustaining vaccine manufacturing network that strengthens Africa’s healthcare resilience and expands global immunization efforts.
Advancing Next-Generation Vaccine Technology
At LunaVax, we recognize that the future of immunization lies in breakthrough vaccine platforms, offering faster development, scalable production, and stronger immunity.
What We’re Exploring
- mRNA vaccines—Rapidly adaptable for emerging diseases and pandemic preparedness.
- Self-amplifying RNA (saRNA) vaccines—A next-gen evolution of mRNA that requires lower doses and has longer-lasting effects.
- Viral vector vaccines—Efficient for diseases requiring strong immune responses.
- DNA-based vaccines — A promising platform offering durable immunity, long-term stability, and easier storage in resource-limited settings.
- Protein subunit vaccines—Ideal for stable, scalable, and broad-based immunization.
These technologies are at the heart of our mission to support Nigeria’s immunization priorities while pushing the boundaries of vaccine science. Together, these platforms support vaccines for priority diseases like hepatitis B, DTP, Hib, and pneumococcal disease, while advancing next-gen solutions for measles, TB, yellow fever, rotavirus—and increasingly, malaria, as new protein-based vaccines gain ground in high-burden regions.
Through strategic partnerships with biotech firms and research institutions, we are working to bring these cutting-edge vaccines to underserved regions, ensuring long-term health security and equitable access. We will keep you updated as we continue to make progress on these groundbreaking vaccine initiatives.
The Future of Vaccine Distribution: Drone-Powered Delivery
When roads fail, drones deliver — bringing vaccines directly to remote communities.
Reaching the last mile in vaccine distribution remains one of the biggest global health challenges. LunaVax is exploring drone logistics as a revolutionary way to deliver vaccines to remote and hard-to-reach areas.
Early-Stage Goals:
- Assess feasibility of autonomous drone delivery
- Build pilot programs with logistics and health partners
- Maintain cold-chain integrity throughout air transport
Our vaccine drone initiative is in its early development phase, but we are committed to transforming it into a breakthrough solution that overcomes last-mile delivery challenges and ensures equitable immunization access.
Expanding Immunization with Tech-Enabled Mobile Units
To expand access, LunaVax is preparing mobile vans, clinics, and pop-up units to reach underserved communities. These smart units will bring vaccines directly to remote areas, overcoming distance, infrastructure gaps, and limited healthcare access.
What sets them apart? Our mobile units are integrated into a drone-powered delivery system, equipped with:
- Biometric verification for accurate patient tracking
- Cold-chain systems to maintain vaccine stability
- Real-time data reporting for improved accountability
Whether it’s at a school, community center, or doorstep, LunaVax’s hybrid approach ensures fast, effective, and equitable vaccine delivery—especially for children and adolescents.
Expanding Access with Next-Gen Tools: Microneedle Patches & Biometric Integration
Painless delivery. Verified identity. Next-gen vaccines, reimagined.
At LunaVax, our mission goes beyond delivering vaccines—it’s about reimagining how we reach people with precision, dignity, and ease. That’s why we’re integrating microneedle patches and biometric tools into our vaccine delivery strategy.
Microneedle Patches: Painless, Powerful, and Scalable
LunaVax is advancing microneedle vaccine patches (MAPs), a simple and painless option designed for remote areas. They don’t require cold-chain storage or highly trained staff, making them an ideal fit for drone and mobile van delivery models.
Our pilot focuses on measles, with plans to expand into malaria and other high-burden diseases. We’re also tracking MAPs for TB and HPV as part of our long-term pipeline.
Biometrics: Smarter Access to Immunization
In regions where health records are limited or non-existent, LunaVax is integrating biometric tools such as fingerprint recognition and digital ID verification to ensure equitable vaccine access. These innovations reduce missed doses, enable accurate patient tracking, and empower healthcare workers with real-time data.
Together, microneedle patches and biometric technologies are helping us build a smarter, more inclusive immunization ecosystem—one that truly leaves no one behind.
What’s Next for LunaVax?
As we lay the groundwork for vaccine innovation and accessibility, we are actively seeking:
- Strategic partnerships with research institutions, governments, and NGOs.
- Investment and funding to accelerate local vaccine production and distribution projects.
- Expert collaborators who share our vision for a world where no one is left behind in immunization efforts.
Want to stay updated?
Sign up for our newsletter to get exclusive insights into LunaVax’s breakthroughs in vaccine innovation. Follow us on [LinkedIn | Instagram | Website] for real-time updates.
Let’s build the future — together.
Join us as we reimagine how vaccines are developed, delivered, and accessed — from lab to last mile.
#BeLunacious
Bridging the vaccine gap takes bold ideas and action. The future is Lunacious!